Table 1.
Comparison of the mechanism of action, common and major adverse events, and out-of-pocket cost of common anti-platelet medications used in stroke prevention.
| Medication | Mechanism of action | Most common adverse events* | Major adverse events | Monthly cost** |
|---|---|---|---|---|
| Cilostazol | Reversible intracellular PDE3 inhibition | Headache, diarrhea, palpitation, dizziness, tachycardia | Contraindicated in patients with heart failure | $9.00 |
| Dipyridamole | Reversible intracellular PDE5 inhibition | Headache, dizziness, abdominal distress, angina pectoris, nausea | Major bleeding (when combined with aspirin) | $73.54 |
| Aspirin | Irreversible extracellular inhibition of COX | Dyspepsia, rash, minor bleeding, epistaxis | Major bleeding, upper gastrointestinal ulcers | $2.47 |
| Clopidogrel | Irreversible extracellular inhibition of P2Y12 | Bruising, minor bleeding, epistaxis | Major bleeding | $15.00 |
| Ticagrelor | Irreversible extracellular inhibition of P2Y12 | Dyspnea, ventricular pause, nausea, dizziness, transient creatinine increase, minor bleeding | Major bleeding, bradyarrhythmia, thrombotic thrombocytopenic purpura | $373.90 |
| Prasugrel | Irreversible extracellular inhibition of P2Y12 | Hypertension, headache, nausea, minor bleeding, epistaxis | Fatal bleeding, thrombotic thrombocytopenic purpura | $32.36 |
According to Lexicomp (online.lexi.com).
According to goodrx.com, in the United States, without insurance, at Walmart.